NGDN

gene
On this page

Also known as DKFZP564O092LCP5lpd-2NGDCANu1

Summary

NGDN (neuroguidin, HGNC:20271) is a protein-coding gene on chromosome 14q11.2, encoding Neuroguidin (Q8NEJ9). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. It is a selective cancer dependency (DepMap: 43.5% of cell lines).

Neuroguidin is an EIF4E (MIM 133440)-binding protein that interacts with CPEB (MIM 607342) and functions as a translational regulatory protein during development of the vertebrate nervous system (Jung et al., 2006 [PubMed 16705177]).

Source: NCBI Gene 25983 — RefSeq curated summary.

At a glance

  • GWAS associations: 15
  • Clinical variants (ClinVar): 76 total
  • Cancer dependency (DepMap): dependent in 43.5% of screened cell lines
  • MANE Select transcript: NM_001042635

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20271
Approved symbolNGDN
Nameneuroguidin
Location14q11.2
Locus typegene with protein product
StatusApproved
AliasesDKFZP564O092, LCP5, lpd-2, NGD, CANu1
Ensembl geneENSG00000129460
Ensembl biotypeprotein_coding
OMIM610777
Entrez25983

Gene structure

Transcript identifiers

Ensembl transcripts: 32 — 22 retained_intron, 10 protein_coding

ENST00000397154, ENST00000408901, ENST00000553336, ENST00000553439, ENST00000555128, ENST00000556103, ENST00000556378, ENST00000556483, ENST00000556580, ENST00000556699, ENST00000556953, ENST00000557097, ENST00000703184, ENST00000703185, ENST00000703186, ENST00000703187, ENST00000703188, ENST00000703189, ENST00000703190, ENST00000703191, ENST00000703192, ENST00000703193, ENST00000703194, ENST00000703195, ENST00000703196, ENST00000703197, ENST00000703256, ENST00000703257, ENST00000703258, ENST00000924623, ENST00000924624, ENST00000955477

RefSeq mRNA: 2 — MANE Select: NM_001042635 NM_001042635, NM_015514

CCDS: CCDS32051, CCDS41926

Canonical transcript exons

ENST00000408901 — 11 exons

ExonStartEnd
ENSE000015792992347750323477560
ENSE000024857172347720023477356
ENSE000039882962347572623475778
ENSE000039882972347555823475642
ENSE000039883122347602923476152
ENSE000039883132347623923476407
ENSE000039883222347517123475308
ENSE000039884792347800723478173
ENSE000039884802347004223470101
ENSE000039884822346970323469727
ENSE000039884862347090623470977

Expression profiles

Bgee: expression breadth ubiquitous, 293 present calls, max score 96.17.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.6772 / max 177.2784, expressed in 1759 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1389319.67721759

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002396.17gold quality
calcaneal tendonUBERON:000370195.60gold quality
ventricular zoneUBERON:000305395.32gold quality
left ovaryUBERON:000211995.01gold quality
body of uterusUBERON:000985394.99gold quality
right ovaryUBERON:000211894.90gold quality
tibial nerveUBERON:000132394.79gold quality
skin of abdomenUBERON:000141694.78gold quality
skin of legUBERON:000151194.42gold quality
endocervixUBERON:000045894.17gold quality
ganglionic eminenceUBERON:000402394.16gold quality
left uterine tubeUBERON:000130394.05gold quality
gastrocnemiusUBERON:000138894.01gold quality
olfactory segment of nasal mucosaUBERON:000538694.01gold quality
cortical plateUBERON:000534393.94gold quality
cerebellar hemisphereUBERON:000224593.93gold quality
popliteal arteryUBERON:000225093.88gold quality
tibial arteryUBERON:000761093.88gold quality
cerebellar cortexUBERON:000212993.85gold quality
right hemisphere of cerebellumUBERON:001489093.82gold quality
muscle layer of sigmoid colonUBERON:003580593.81gold quality
islet of LangerhansUBERON:000000693.74gold quality
muscle of legUBERON:000138393.69gold quality
esophagogastric junction muscularis propriaUBERON:003584193.63gold quality
omental fat padUBERON:001041493.62gold quality
peritoneumUBERON:000235893.61gold quality
zone of skinUBERON:000001493.55gold quality
left lobe of thyroid glandUBERON:000112093.55gold quality
mucosa of stomachUBERON:000119993.55gold quality
aortaUBERON:000094793.54gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-110499no526.73
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

18 targeting NGDN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-6744-5P99.9366.82748
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-10523-5P99.9169.222038
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-7113-5P97.8867.331735
HSA-MIR-3664-3P97.8567.621452
HSA-MIR-608596.5764.11621
HSA-MIR-6813-5P94.6864.20588

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 43.5% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • Study isolated a novel human gene, to be called as CANu1, by the large-scale genome-wide association analysis to screen specific Single nucleotide polymorphisms in colon cancer. (PMID:18547334)
  • poly(A) polymerase Gld2, deadenylase PARN, and translation inhibitory factor neuroguidin (Ngd) are components of a dendritic CPEB-associated polyadenylation apparatus (PMID:22727665)
  • the results of this study in vitro confirmed that NGDN over-expression can increase the sensitivity of human myeloid multidrug-resistant leukemia cells to chemotherapeutic drugs (PMID:25887473)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriongdnENSDARG00000045372
mus_musculusNgdnENSMUSG00000022204
rattus_norvegicusNgdnENSRNOG00000018069
drosophila_melanogasterCG11030FBGN0031736
caenorhabditis_eleganslpd-2WBGENE00003059

Paralogs (1): UTP3 (ENSG00000132467)

Protein

Protein identifiers

NeuroguidinQ8NEJ9 (reviewed: Q8NEJ9)

Alternative names: Centromere accumulated nuclear protein 1, EIF4E-binding protein

All UniProt accessions (6): Q8NEJ9, A0A8V8TQS3, A0A8V8TRJ3, G3V4G1, H0YJ17, H0YJQ1

UniProt curated annotations — full annotation on UniProt →

Function. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Its dissociation from the complex determines the transition from state pre-A1 to state pre-A1*. Inhibits mRNA translation in a cytoplasmic polyadenylation element (CPE)-dependent manner.

Subunit / interactions. Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3. Interacts with CPEB1 and EIF4E.

Subcellular location. Nucleus. Nucleolus. Chromosome. Centromere. Cytoplasm. Cell projection. Axon. Dendrite. Filopodium.

Miscellaneous. May be due to a competing donor splice site.

Similarity. Belongs to the SAS10 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8NEJ9-11yes
Q8NEJ9-22

RefSeq proteins (2): NP_001036100, NP_056329 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007146Sas10/Utp3/C1DFamily

Pfam: PF04000

UniProt features (19 total): modified residue 6, region of interest 3, splice variant 2, sequence variant 2, coiled-coil region 2, compositionally biased region 2, initiator methionine 1, chain 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
7MQ8ELECTRON MICROSCOPY3.6

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NEJ9-F175.850.29

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 121, 142, 143, 204, 214, 2

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 154 (showing top): GOBP_RIBOSOME_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA, MORF_UBE2I, PUJANA_CHEK2_PCC_NETWORK, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, WANG_LMO4_TARGETS_DN, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA, GOCC_NEURON_PROJECTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOCC_FILOPODIUM, GOCC_CHROMOSOMAL_REGION

GO Biological Process (3): maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462), regulation of translation (GO:0006417), ribosomal small subunit biogenesis (GO:0042274)

GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)

GO Cellular Component (12): chromosome, centromeric region (GO:0000775), nucleoplasm (GO:0005654), nucleolus (GO:0005730), mitochondrion (GO:0005739), filopodium (GO:0030175), axon (GO:0030424), dendrite (GO:0030425), small-subunit processome (GO:0032040), nucleus (GO:0005634), chromosome (GO:0005694), cytoplasm (GO:0005737), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
nuclear lumen2
intracellular membraneless organelle2
intracellular membrane-bounded organelle2
neuron projection2
maturation of SSU-rRNA1
translation1
post-transcriptional regulation of gene expression1
regulation of protein metabolic process1
ribonucleoprotein complex biogenesis1
ribosome biogenesis1
nucleic acid binding1
binding1
chromosomal region1
cytoplasm1
actin-based cell projection1
dendritic tree1
nucleolus1
preribosome1
t-UTP complex1
nuclear protein-containing complex1
intracellular anatomical structure1

Protein interactions and networks

STRING

2185 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NGDNEIF4EP06730998
NGDNCPEB1Q9BZB8961
NGDNNOL10Q9BSC4862
NGDNTENT2Q6PIY7861
NGDNPARNO95453839
NGDNSYMPKQ92797820
NGDNEIF4ENIF1Q9NRA8793
NGDNAATFQ9NY61791
NGDNEIF4G1Q04637721
NGDNABT1Q9ULW3705
NGDNPNLDC1Q8NA58705
NGDNRPTORQ8N122704
NGDNPAPOLBQ9NRJ5688
NGDNPAPOLAP51003686
NGDNPAPOLGQ9BWT3686

IntAct

115 interactions, top by confidence:

ABTypeScore
AATFNGDNpsi-mi:“MI:0915”(physical association)0.810
AATFNGDNpsi-mi:“MI:0914”(association)0.810
PKN3ARHGAP10psi-mi:“MI:0914”(association)0.680
repMPHOSPH10psi-mi:“MI:0914”(association)0.660
LIN28AIGF2BP3psi-mi:“MI:0914”(association)0.640
NPM1MPHOSPH10psi-mi:“MI:0914”(association)0.610
MFAP1NGDNpsi-mi:“MI:0915”(physical association)0.560
CSNK2BNGDNpsi-mi:“MI:0915”(physical association)0.560
NOM1NGDNpsi-mi:“MI:0915”(physical association)0.560
RPS3ZNF316psi-mi:“MI:0914”(association)0.530
H1-6ZNF724psi-mi:“MI:0914”(association)0.530
ZNF512ZNF724psi-mi:“MI:0914”(association)0.530
RPS2MPHOSPH10psi-mi:“MI:0914”(association)0.530
KRR1MPHOSPH10psi-mi:“MI:0914”(association)0.530
ABT1ZNF316psi-mi:“MI:0914”(association)0.530
NOL10DDX10psi-mi:“MI:0914”(association)0.530
NGDNpsi-mi:“MI:0915”(physical association)0.500
NGDNSLC16A1psi-mi:“MI:0915”(physical association)0.400
RRP1BZNF785psi-mi:“MI:0914”(association)0.350
psi-mi:“MI:0914”(association)0.350
Prdm16ESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (158): AATF (Two-hybrid), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), UTP3 (Co-fractionation), NGDN (Affinity Capture-MS), NGDN (Biochemical Activity), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Affinity Capture-MS), NGDN (Proximity Label-MS), NGDN (Affinity Capture-MS)

ESM2 similar proteins: A1A5P2, A6QNR1, A8WY26, D3ZND0, O15213, O59678, P27672, P78316, Q0V8M0, Q15050, Q24K12, Q28IV8, Q2KIH4, Q2KII6, Q3T0Q8, Q3T0Z5, Q3UFY0, Q4KLC4, Q5M985, Q5RAS1, Q5RJT2, Q5TAP6, Q5TJE7, Q5ZKM1, Q640M1, Q6EJB6, Q6P0I6, Q6PFJ1, Q8BK35, Q8IY81, Q8N9T8, Q8NEJ9, Q8R3N1, Q8VDQ9, Q96BZ8, Q96EU6, Q9BRP8, Q9BRR8, Q9BVJ6, Q9C086

Diamond homologs: Q09713, Q2KII6, Q8NEJ9, Q9DB96, Q28IV8, Q4KLC4, Q5M985, Q6PFJ1, Q6AXX4, Q8L3P4, Q9JI13, Q9NQZ2, Q1MTS0, Q9I7W5

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 111 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Eukaryotic Translation Initiation1144.7×7e-15
Cap-dependent Translation Initiation1144.7×7e-15
SARS-CoV-1 modulates host translation machinery1144.7×7e-15
Eukaryotic Translation Elongation1140.3×2e-14
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S1139.4×3e-14
Nonsense-Mediated Decay (NMD)1133.7×2e-13
Peptide chain elongation2033.4×1e-23
Viral mRNA Translation2033.4×1e-23

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation2137.8×4e-25
ribosomal small subunit biogenesis1328.7×1e-13
translation1919.0×8e-17
rRNA processing1013.8×5e-07
RNA processing510.6×8e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

76 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance61
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1143 predictions. Top by Δscore:

VariantEffectΔscore
14:23470040:AGGG:Aacceptor_gain1.0000
14:23470041:GGGG:Gacceptor_gain1.0000
14:23470098:GCAA:Gdonor_gain1.0000
14:23470102:G:GGdonor_gain1.0000
14:23470889:ATTT:Aacceptor_gain1.0000
14:23470889:ATTTG:Aacceptor_gain1.0000
14:23470892:T:Aacceptor_gain1.0000
14:23470893:G:Aacceptor_gain1.0000
14:23470898:A:AGacceptor_gain1.0000
14:23470900:TTTCA:Tacceptor_loss1.0000
14:23470901:TTCAG:Tacceptor_loss1.0000
14:23470902:TCAGG:Tacceptor_loss1.0000
14:23470904:A:AGacceptor_gain1.0000
14:23470904:AG:Aacceptor_gain1.0000
14:23470904:AGGT:Aacceptor_gain1.0000
14:23470905:G:Aacceptor_loss1.0000
14:23470905:G:GTacceptor_gain1.0000
14:23470905:GG:Gacceptor_gain1.0000
14:23470905:GGT:Gacceptor_gain1.0000
14:23470905:GGTG:Gacceptor_gain1.0000
14:23470975:AAGG:Adonor_loss1.0000
14:23470975:AAGGT:Adonor_gain1.0000
14:23470976:AGG:Adonor_gain1.0000
14:23470977:GGTAA:Gdonor_gain1.0000
14:23470978:G:GGdonor_gain1.0000
14:23470978:GTA:Gdonor_gain1.0000
14:23470979:T:Adonor_gain1.0000
14:23475154:T:Aacceptor_gain1.0000
14:23475159:T:Aacceptor_gain1.0000
14:23475164:A:AGacceptor_gain1.0000

AlphaMissense

2063 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:23476320:T:CL209P0.997
14:23476320:T:AL209H0.996
14:23477212:G:CE242D0.996
14:23477212:G:TE242D0.996
14:23475592:T:CL106P0.994
14:23477211:A:TE242V0.994
14:23475304:G:CR93P0.993
14:23476119:T:CY171H0.990
14:23477228:C:AR248S0.989
14:23475202:T:CL59P0.987
14:23477309:T:CF275L0.987
14:23477311:C:AF275L0.987
14:23477311:C:GF275L0.987
14:23475609:A:GK112E0.986
14:23475611:G:CK112N0.986
14:23475611:G:TK112N0.986
14:23476308:T:AV205D0.986
14:23476292:G:CA200P0.985
14:23475235:T:CL70P0.984
14:23476311:T:AI206N0.984
14:23476344:C:AP217Q0.984
14:23475194:A:CK56N0.983
14:23475194:A:TK56N0.983
14:23475217:T:CL64P0.983
14:23476120:A:GY171C0.983
14:23476320:T:GL209R0.983
14:23475613:T:CL113P0.982
14:23476119:T:GY171D0.982
14:23476301:A:CS203R0.982
14:23476303:C:AS203R0.982

dbSNP variants (sampled 300 via entrez): RS1000009557 (14:23474579 A>C,G), RS1000615173 (14:23476038 G>A,C), RS1000677117 (14:23473991 C>G,T), RS1001025190 (14:23475674 G>A,C), RS1001403420 (14:23474974 C>T), RS1001455882 (14:23474724 T>G), RS1001842060 (14:23470874 C>T), RS1002354505 (14:23478651 G>T), RS1002376027 (14:23470561 G>A), RS1002465148 (14:23472902 G>A), RS1002657377 (14:23473079 G>A), RS1002846471 (14:23470146 T>C), RS1002962381 (14:23470432 T>A), RS1003078753 (14:23476310 A>G), RS1003118971 (14:23475515 T>C,G)

Disease associations

OMIM: gene MIM:610777 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

15 associations (top):

StudyTraitp-value
GCST010796_5083Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-20
GCST010796_5084Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-08
GCST010796_5085Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-09
GCST010796_5086Electrocardiogram morphology (amplitude at temporal datapoints)7.000000e-11
GCST010796_5087Electrocardiogram morphology (amplitude at temporal datapoints)2.000000e-12
GCST010796_5088Electrocardiogram morphology (amplitude at temporal datapoints)2.000000e-13
GCST010796_5089Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-14
GCST010796_5090Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-15
GCST010796_5091Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-16
GCST010796_5092Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-17
GCST010796_5093Electrocardiogram morphology (amplitude at temporal datapoints)2.000000e-18
GCST010796_5094Electrocardiogram morphology (amplitude at temporal datapoints)5.000000e-19
GCST010796_5095Electrocardiogram morphology (amplitude at temporal datapoints)3.000000e-19
GCST010796_5096Electrocardiogram morphology (amplitude at temporal datapoints)1.000000e-19
GCST010796_5097Electrocardiogram morphology (amplitude at temporal datapoints)9.000000e-20

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004327electrocardiography

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tobacco Smoke Pollutionaffects expression, increases expression2
FR900359affects phosphorylation1
dicrotophosdecreases expression1
bisphenol Adecreases expression1
deoxynivalenolincreases expression1
beta-lapachoneincreases expression1
arseniteaffects binding, increases reaction1
zinc chromateincreases expression, increases abundance1
coumarinincreases phosphorylation1
chromium hexavalent ionincreases abundance, increases expression1
cylindrospermopsinincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
ICG 001decreases expression1
abrineincreases expression1
LDN 193189affects cotreatment, decreases expression1
(+)-JQ1 compounddecreases expression1
Sunitinibincreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Caffeinedecreases phosphorylation1
Copperaffects binding, decreases expression1
Disulfiramaffects binding, decreases expression1
Formaldehydeincreases expression1
Ribonucleotidesaffects binding1
Dronabinoldecreases expression1
Thiramincreases expression1
Valproic Acidaffects expression1
Aflatoxin B1increases methylation1
Cadmium Chloridedecreases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.